INT48447

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.59
First Reported 1994
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 0.93
Pain Relevance 0.66

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (IL3) extracellular region (IL3) cell-cell signaling (IL3)
Anatomy Link Frequency
blood 1
IL3 (Homo sapiens)
Pain Link Frequency Relevance Heat
cytokine 95 100.00 Very High Very High Very High
tolerance 3 99.08 Very High Very High Very High
antagonist 34 98.92 Very High Very High Very High
aspirin 1 93.80 High High
headache 2 74.52 Quite High
Inflammation 96 70.92 Quite High
agonist 20 42.64 Quite Low
withdrawal 2 37.76 Quite Low
chemokine 23 5.00 Very Low Very Low Very Low
Inflammatory response 6 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Asthma 315 96.32 Very High Very High Very High
Eosinophilia 19 91.52 High High
Cv General 2 Under Development 1 76.52 Quite High
Headache 2 74.52 Quite High
INFLAMMATION 103 70.92 Quite High
Rhinitis 11 55.52 Quite High
Fever 2 53.04 Quite High
Arthralgia 1 47.60 Quite Low
Vomiting 2 41.60 Quite Low
Targeted Disruption 20 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Present and future clinical relevance of interleukin 3.
Localization (relevance) of interleukin 3 associated with cytokine
1) Confidence 0.59 Published 1994 Journal Stem Cells Section Title Doc Link 7696963 Disease Relevance 0.15 Pain Relevance 0.12
A pilot study was devised to assess tolerance of combined administration of interleukin-3 (IL-3) and granulocyte-colony stimulating factor (G-CSF) given after chemotherapy to mobilize peripheral blood progenitors cells (PBPC).
Localization (mobilize) of IL-3 in blood associated with tolerance
2) Confidence 0.15 Published 1994 Journal Bone Marrow Transplant. Section Abstract Doc Link 7515299 Disease Relevance 0.05 Pain Relevance 0.12
In vitro, the cysteinyl-leukotriene receptor antagonist pranlukast can concentration-dependently inhibit the release of Th2 cytokines (IL-3, IL-4, GM-CSF), but not of the Th1 cytokine IL-2, from mite allergen-stimulated PBMCs from asthmatic patients [37].
Localization (release) of IL-3 associated with asthma, antagonist and cytokine
3) Confidence 0.08 Published 2008 Journal J Occup Med Toxicol Section Body Doc Link PMC2259400 Disease Relevance 0.72 Pain Relevance 0.42

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox